Table 1.
Variables | Favorable outcome | Poor outcome | p value |
---|---|---|---|
( n = 169) | ( n = 65) | ||
Demographic characteristics | |||
Age (years) | 66 (55.5-75) | 75 (67-82.5) | <0.001 |
Sex (male, n %) | 112 (66.3) | 38 (58.5) | 0.265 |
Vascular risk factors, (n %) | |||
Hypertension (n %) | 107 (63.3) | 51 (78.5) | 0.027 |
Diabetes (n %) | 73 (43.2) | 30 (46.2) | 0.683 |
Hyperlipidemia (n %) | 52 (30.8) | 22 (33.8) | 0.650 |
History of stroke (n %) | 15 (8.9) | 14 (21.5) | 0.008 |
Atrial fibrillation (n %) | 42 (24.9) | 34 (52.3) | <0.001 |
Clinical data | |||
Baseline NIHSS | 6.00 (4.00-9.00) | 13.00 (8.00-18.00) | <0.001 |
Laboratory indexes | |||
WBC (×109/L) | 7.08 ± 1.85 | 8.66 ± 2.58 | <0.001 |
RBC (×1012/L) | 4.41 ± 0.49 | 4.28 ± 0.53 | 0.078 |
Platelet (×109/L) | 197.35 ± 54.89 | 197.88 ± 57.35 | 0.948 |
Albumin (g/L) | 38.18 ± 2.92 | 38.06 ± 3.21 | 0.788 |
Globulin (g/L) | 26.70 ± 3.90 | 28.95 ± 4.94 | <0.001 |
Prealbumin (g/L) | 0.23 (0.20-0.27) | 0.22 (0.18-0.25) | 0.005 |
UA (μmol/L) | 331.48 ± 81.44 | 317.78 ± 98.03 | 0.278 |
BUN (mmol/L) | 4.60 (3.95-5.67) | 5.28 (4.03-6.22) | 0.060 |
TC (mmol/L) | 4.53 (4.01-5.24) | 4.67 (3.69-5.61) | 0.601 |
HDL-C (mmol/L) | 1.07 (0.94-1.28) | 1.03 (0.89-1.34) | 0.660 |
LDL-C (mmol/L) | 2.90 ± 0.90 | 3.07 ± 1.07 | 0.219 |
Apo-A1 (g/L) | 1.29 (1.17-1.43) | 1.23 (1.10-1.49) | 0.357 |
Apo-B1 (g/L) | 0.92 (0.78-1.06) | 0.93 (0.81-1.12) | 0.453 |
GPR | 111.92 (93.74-135.75) | 136.32 (106.05-174.08) | <0.001 |
GAR | 0.70 ± 0.11 | 0.77 ± 0.13 | 0.001 |
Abbreviations: NIHSS: National Institute of Health Stroke Scale; WBC: white blood cell count; UA: uric acid; RBC: red blood cells; BUN: blood urea nitrogen; TC: triglyceride; HDL-C: high density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; Apo-A1: apolipoprotein-A1; Apo-B1: apolipoprotein-B1; GPR: globulin to prealbumin ratio; GAR: globulin to albumin ratio.